Bridgeway Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$655K Sell
34,970
-12,500
-26% -$234K 0.02% 725
2025
Q1
$854K Sell
47,470
-15,400
-24% -$277K 0.02% 667
2024
Q4
$1.06M Sell
62,870
-1,670
-3% -$28.1K 0.02% 656
2024
Q3
$1.04M Hold
64,540
0.02% 673
2024
Q2
$531K Buy
64,540
+5,000
+8% +$41.1K 0.01% 845
2024
Q1
$881K Sell
59,540
-7,500
-11% -$111K 0.02% 772
2023
Q4
$972K Buy
67,040
+7,620
+13% +$110K 0.02% 768
2023
Q3
$642K Buy
59,420
+21,920
+58% +$237K 0.02% 820
2023
Q2
$484K Buy
37,500
+11,500
+44% +$148K 0.01% 914
2023
Q1
$343K Sell
26,000
-6,500
-20% -$85.8K 0.01% 976
2022
Q4
$488K Hold
32,500
0.01% 885
2022
Q3
$384K Buy
+32,500
New +$384K 0.01% 963
2017
Q4
Sell
-15,780
Closed -$401K 1438
2017
Q3
$401K Hold
15,780
﹤0.01% 1145
2017
Q2
$431K Hold
15,780
0.01% 1131
2017
Q1
$522K Hold
15,780
0.01% 1061
2016
Q4
$376K Sell
15,780
-4,000
-20% -$95.3K ﹤0.01% 1174
2016
Q3
$726K Buy
19,780
+780
+4% +$28.6K 0.01% 927
2016
Q2
$424K Hold
19,000
0.01% 1113
2016
Q1
$395K Sell
19,000
-530
-3% -$11K 0.01% 1133
2015
Q4
$592K Sell
19,530
-3,650
-16% -$111K 0.01% 987
2015
Q3
$573K Buy
23,180
+3,650
+19% +$90.2K 0.01% 960
2015
Q2
$627K Sell
19,530
-230
-1% -$7.38K 0.01% 963
2015
Q1
$705K Hold
19,760
0.01% 942
2014
Q4
$449K Sell
19,760
-9,490
-32% -$216K 0.01% 1114
2014
Q3
$567K Buy
29,250
+1,640
+6% +$31.8K 0.01% 1015
2014
Q2
$1M Buy
27,610
+13,270
+93% +$482K 0.03% 776
2014
Q1
$556K Buy
+14,340
New +$556K 0.02% 1024